Search Investor Updates

Investor Update provides you with up to date and informative articles about the investment climate in Australia.

Japan’s biggest pharma co., Takeda, teams with Melbourne’s BioCurate to expedite new drug development

29 Nov 2019

Victorian medicines accelerator, BioCurate, is partnering with Takeda Pharmaceutical Company Limited to expedite the development of new therapeutics and drugs.

Read article...

Korea and Australia strengthen research ties in early drug development

1 Nov 2019

Korea’s Yuhan Corporation announced on 1 November that it has signed a Memorandum of Understanding (MoU) with one of Australia’s oldest research institutions, the 104-year-old Walter and Eliza Hall In ...

Read article...

Strategic investment in Victorian app developer from top US healthcare co.

18 Oct 2019

Major US healthcare provider HMS is investing US$7.5 million in Australian digital health company, MedAdvisor, in a move that could help tackle the global issue of patient non-adherence to medications ...

Read article...

Servier and BioCurate to collaborate on new drug discoveries

5 Aug 2019

French pharmaceutical company Servier Group, through its Australian subsidiary, and Australia’s BioCurate will share commercial and scientific expertise to accelerate the discovery of new therapeutics ...

Read article...

US biotech firm signs new research agreement with UTS

29 Jul 2019

California-based PharmaCyte Biotech and the University of Technology Sydney (UTS) have signed a research agreement to develop a new version of Melligen cells that can potentially express higher levels ...

Read article...

Korean genome co invests A$4m to take Queensland microbiome project global

20 Jun 2019

Seoul-based genome specialist, Macrogen, has agreed a A$4.1 million investment in the Queensland microbiome testing and bioinformatics company, Microba.

Read article...

How Australia’s top-five digital health innovation sectors attract global investment

19 Jun 2019

Austrade has launched a digital health website showcasing Australia as an ideal location for developing, testing and launching the next generation of digital medical technologies.

Read article...

US biotech injects 3D printing expertise into Victorian artificial kidney project

13 Jun 2019

San Diego-based biotechnology company, Organovo Holdings (Organovo), has announced a tie up with a Melbourne research institute to help develop regenerative medicine in Australia.

Read article...

Precision health strategy gets boost from Chinese gene sequencer

12 Jun 2019

Chinese genome sequencing company, BGI Genomics (BGI), and Australian health-data expert, Pryzm Health (Pryzm) have announced a collaboration designed to bring genome-related precision health services ...

Read article...

US biotech company sets up HQ in Australia

17 Apr 2019

Praxis Precision Medicines has chosen Australia to be its Asia-Pacific headquarters and research and development (R&D) centre.

Read article...

Monash medical tie-up to stem post-natal fatalities

28 Mar 2019

Belgium-based Janssen Pharmaceutica N.V. is sponsoring a research program at the Monash Institute of Pharmaceutical Sciences (MIPS) that may dramatically reduce the incidence of post-natal fatalities ...

Read article...

Clinical trials success showcases Korea–Australia pharma collaboration

27 Feb 2019

Korean biopharma company, PharmAbcine, is commencing full-scale clinical trials of a brain cancer treatment in the United States, following pioneering early phase trials in Australia.

Read article...

Korean collaboration brings gene-splicing genius to Melbourne cancer project

13 Feb 2019

Australia’s world-class Medtech research has received an overseas boost, with Korean gene-editing specialist, ToolGen, signing a collaborative partnership with Melbourne-based biotech company, Carther ...

Read article...

Australian digital diagnostics firm partners with QIAGEN on TB testing solution

22 Jan 2019

Australian digital diagnostics firm Ellume has partnered with German-Dutch company QIAGEN to develop a new tuberculosis (TB) testing solution for developing nations with a high disease burden of TB

Read article...

Japanese tech titan Hitachi joins Western Sydney precinct project

3 Dec 2018

Japanese technology conglomerate Hitachi has signed a memorandum of understanding (MoU) with the NSW Government to collaborate on the development of the Western Parkland City and Western Sydney Aerotr ...

Read article...

Takeda awards A$100,000 Australian medical research grants

29 Nov 2018

Takeda, Japan’s largest pharmaceutical company, has awarded individual grants of approximately A$100,000 to four Australian research programs as part of its COCKPI-T open innovation program

Read article...

Australia holds world record for longest period of growth among developed economies

28 Nov 2018

Australia's economy grew by a stronger-than-expected 0.9% in seasonally adjusted terms over the June quarter 2018, according to the latest National Accounts figures recently released by the Australian ...

Read article...

US medical device maker partners with GenesisCare on cancer research and treatment

23 Nov 2018

Varian and GenesisCare have signed a memorandum of understanding (MoU) to form a strategic partnership for cancer care research and to increase access to advanced cancer care across Australia.

Read article...

UK pharmaceutical links up with Australian biotech to develop needle-free vaccines

22 Nov 2018

Enesi Pharma in the UK and Australian biotechnology firm Sementis have signed a research and development (R&D) collaborative agreement to develop vaccines to treat peanut allergy and mosquito-borne in ...

Read article...

Novartis and BioCurate to work together on early-stage drug discovery

21 Nov 2018

Global biopharmaceutical Novartis and Australian biomedical research company BioCurate have signed a memorandum of understanding (MoU) to share research and accelerate discoveries of new drugs.

Read article...